2X10.SG Overview

Company Profile

Related stocks

ABVX.PA • France

ABIVAX

79 EUR

7.73B USD 1Y +1%

ASND • Denmark

Ascendis Pharma A/S

229.23 USD

15.08B USD 1Y +6%

TUB.BR • Belgium

TUBIZE-FIN

170 EUR

8.48B USD 1Y -27%

ALK-B.CO • Denmark

ALK-Abelló B A/S

227.4 DKK

7.55B USD 1Y +5.6%

JAZZ • Ireland

Jazz Pharmaceuticals plc

218.42 USD

14.18B USD 1Y +61.5%

NAMS • Netherlands

NewAmsterdam Pharma Company N.V

21.58 USD

2.58B USD 1Y -35.3%

DBV.PA • France

DBV TECHNOLOGIES

1.68 EUR

590.88M USD 1Y -38.1%

BANB.SW • Switzerland

BACHEM N

80.05 CHF

7.23B USD 1Y +37.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

364.9% p.a.

Max Drawdown (3Y)

-69.3%

Sharpe Ratio (3Y)

0.29

Beta Factor

-0.23

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.